|
|
Volumn 15, Issue 3, 2014, Pages
|
|
Idelalisib: targeting PI3Kδ in B-cell malignancies.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IDELALISIB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PIK3CD PROTEIN, HUMAN;
PURINE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
HUMAN;
NONHODGKIN LYMPHOMA;
NOTE;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
LYMPHOMA, NON-HODGKIN;
PHOSPHATIDYLINOSITOL 3-KINASES;
PURINES;
QUINAZOLINONES;
MLCS;
MLOWN;
|
|
EID: 84900825956
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/s1470-2045(14)70052-x Document Type: Note |
|
Times cited : (15)
|
|
References (0)
|
